← Leaderboards
Kevin Jeng-Yen Lin
University Of Minnesota
$140,595
Attributed
$140,595
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2021–23$100K$75K$50K$25K$0
'21
'22
'23
Funding mix
By agency
NIH$140,595 · 1
By mechanism
F30$140,595 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Bruce R. Blazar$144,460,093
- Syed Arslan Abbas Zaidi$1,193,280
- Frank Wolfgang Albert$5,542,840
- Stephane Angers$1,341,861
Others in their field
Other Emerging Leaders on “Acute Myeloid Leukemia Cell”
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,329,699
- Benjamin G Vincent · Univ Of North Carolina Chapel Hill$3,644,761
- Jeffrey Alan Magee · Washington University$3,546,780
- Amanda M Schalk · Enzyme By Design, Inc.$3,543,028
- Rolf Muller · Biofluidica, Inc$3,253,766
Research focus
Acute Myeloid Leukemia CellAlgorithmsAnalysis PipelineBiochemicalBiologicalBiological ProcessBiological SciencesBiologyCancer PatientCell LineCellsCell SurvivalChemical ActionsChemical GeneticsClinical OncologyClustered Regularly Interspaced Short Palindromic RepeatsCollectionComputational PipelinesComputerized ToolsComputing MethodologiesCostCrispr/Cas TechnologyCrispr LibraryAcute Myelocytic Leukemia
Grant awards (3)
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics$40,252
F30 · FY2023 · CA · contact PI
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics$51,752
F30 · FY2022 · CA · contact PI
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics$48,591
F30 · FY2021 · CA · contact PI